NCT07252713

Brief Summary

The primary goal of CP-MOVES is to evaluate 1) the preliminary efficacy of a telehealth-delivered, parent coaching intervention in the use of adaptive standers, on physical activity, sleep, and endurance in young children with severe motor delays and 2) on physical activity, sedentary time, resting heart rate, and perceived stress in parents. The main questions the study aims to answer include:

  1. 1.Do measures of physiological fitness and sleep in children with severe motor delays (i.e., unable to stand without support) change after a therapist-directed, parent-delivered intervention using telehealth and adaptive standers?
  2. 2.Do parents report any changes in their child's endurance, participation, or quality of life OR parent stress following intervention?
  3. 3.Complete three 30 minute sessions of standing in an adapted stander per week for 8 weeks. One session per week will be completed with a physical therapist, delivered through telehealth and two sessions per week will be completed as a home program with the parent and child (no therapist or telehealth).
  4. 4.Wear activity tracker sensors on the wrist(s) and waist for one-week before and after treatment.
  5. 5.Complete questionnaires about the child's endurance, participation, and quality of life and the parent's stress, before and after treatment.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
7mo left

Started Feb 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress27%
Feb 2026Dec 2026

First Submitted

Initial submission to the registry

November 17, 2025

Completed
11 days until next milestone

First Posted

Study publicly available on registry

November 28, 2025

Completed
3 months until next milestone

Study Start

First participant enrolled

February 19, 2026

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2026

Expected
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Last Updated

April 16, 2026

Status Verified

February 1, 2026

Enrollment Period

7 months

First QC Date

November 17, 2025

Last Update Submit

April 13, 2026

Conditions

Keywords

Assistive DeviceStanderPhysical ActivitySedentaryParentPhysical TherapyRehabilitationDigital HealthTelehealthWearable Sensors

Outcome Measures

Primary Outcomes (7)

  • Wearable sensor physical activity data: Vector Magnitude

    Vector Magnitude is a measure of moderate to vigorous physical activity measured in G-Force units. To be measured pre/post in parent and child. Higher values indicate greater intensity of movement. Values range from 0 (sedentary) to very vigorous (\>9500). Expect increase in vector magnitude with intervention.

    From enrollment to end of 8-week treatment period

  • Wearable sensor physical activity data: Daily Activity Counts

    Wearable sensor outcomes measured in parent and child. Daily Activity Counts are a measure of frequency and intensity of physical activity, converted from raw acceleration data to unitless count data. Measure of activity over the whole day (expressed in minutes from 0-1440 per day) and binned into Sedentary, Light or Moderate/Vigorous physical activity. Expect increase in light and/or moderate to vigorous physical activity following intervention.

    From enrollment to end of 8-week treatment period

  • Wearable sensor physical activity data: Average Resting Heart Rate

    Wearable sensor outcomes measured in parent and child., Average resting heart rate, measure in beats per minute, provides a measure of cardiorespiratory fitness. Normative values range from 50-100 beats per minute (adults and children, slightly higher in infants) with lower values indicating better fitness. Exploratory, but anticipate improved fitness (therefore lower resting heart rate) with intervention.

    From enrollment to end of 8-week treatment period

  • Wearable sensor physical activity data

    Wearable sensor outcomes measured in parent and child. Daily sedentary time, measured in minutes, quantifies the amount of time per day spent sitting, lying or otherwise stationary. Measured in minutes (range: 0-1440 per day). Less sedentary time is ideal. Expect less sedentary time following intervention.

    From enrollment to end of 8-week treatment period

  • Sleep wearable sensor data: total sleep time

    Sleep data measured in child only. Total sleep time is the amount of time, in minutes, that the child is sleeping. Measured in minutes (0-1440 minutes per day). Normative range from children ages 1-6 years is 9-14 hours per day. Exploratory measure, expect sleep to stay the same or slightly increase with increased physical activity.

    From enrollment until end of treatment period ( 8 weeks)

  • Sleep wearable sensor data: Sleep Latency

    Sleep data measured in child only. Sleep latency is a measure of the time gap between when the child lays down at bedtime until they fall asleep, as measured by the wearable sensor. Sleep latency is measured in minutes (range: 0-1440 minutes in a single day). Exploratory, but expect sleep latency time to decrease.

    From enrollment until end of treatment period ( 8 weeks)

  • Sleep wearable sensor data: Sleep efficiency

    Sleep data measured in child only. Sleep efficiency is the proportion of time in bed that the child is asleep and is reported as a percentage (range 0-100%). Exploratory variable, but expect values to improve with intervention.

    From enrollment until end of treatment period ( 8 weeks)

Secondary Outcomes (4)

  • Caregiver Priorities and Child Health Index of Life with Disabilities (CP-CHILD)

    before and after 8-week intervention

  • Young Child-Participation in Environment Measure (YC-PEM)

    Before and after 8-week treatment

  • The Early Activity Scale for Endurance (EASE)

    Before and after 8 week treatment

  • Perceived Stress Scale-14 (PSS-14)

    Before and after 8-week treatment period

Study Arms (1)

Telehealth-delivered parent coaching intervention in adaptive stander use

EXPERIMENTAL

Children will receive an adaptive stander and complete 30-minute sessions 3 times per week for 8 weeks. One session per week will be telehealth-delivered with a study researcher.

Behavioral: Stander Use

Interventions

Stander UseBEHAVIORAL

The intervention includes 8 weeks of adaptive standing training delivered via telehealth with PT parent-coaching (1 telehealth session/week + 2 parent-led practice sessions/week). Sessions are 30 minutes, 3x/ week. Participants are provided a stander, sized to their age and body size for use during the study.

Telehealth-delivered parent coaching intervention in adaptive stander use

Eligibility Criteria

Age1 Year - 6 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Child age 1-6 years with CP or other severe motor delay (GMFCS IV-V);
  • Unable to stand without external support;
  • Parent willing and able to participate;
  • Internet access for telehealth;
  • Live within 100 miles of lab or travel for device provision,
  • One parent is fluent in English.

You may not qualify if:

  • Inability to participate in telehealth
  • Parent/caregiver unable to participate

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Pediatric Assessment and Rehabilitation Lab

Columbus, Ohio, 43221, United States

RECRUITING

MeSH Terms

Conditions

Cerebral PalsyPsychomotor DisordersMotor ActivitySedentary Behavior

Condition Hierarchy (Ancestors)

Brain Damage, ChronicBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesNeurobehavioral ManifestationsNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsBehavior

Study Officials

  • Jill Heathcock, PhD

    Ohio State University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director, PEARL Lab

Study Record Dates

First Submitted

November 17, 2025

First Posted

November 28, 2025

Study Start

February 19, 2026

Primary Completion (Estimated)

October 1, 2026

Study Completion (Estimated)

December 1, 2026

Last Updated

April 16, 2026

Record last verified: 2026-02

Locations